Jon Hinman
Pain Medicine · Wasilla, AKNPI 1518980556
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $622 and has fallen 86.6% since, to $83 in 2025.
Across 82 payments — averaging $22.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$446
- Nevro Corp.$396
- AbbVie$221
- Collegium Pharmaceutical, Inc.$150
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$122
- Pacira Therapeutics, Inc.$119
- plus $425 from 14 others
What the payments were for
- Food & beverage$1,879100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 31 | $446 |
| Nevro Corp. | 8 | $396 |
| AbbVie(2 entities) | 7 | $221 |
| Collegium Pharmaceutical, Inc. | 5 | $150 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $122 |
| Pacira Therapeutics, Inc. | 5 | $119 |
| Abbott | 1 | $85 |
| Biohaven Pharmaceuticals, Inc. | 4 | $73 |
| Tactile Systems Technology Inc | 1 | $44 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $35 |
| Alfasigma USA, Inc. | 1 | $27 |
| Pfizer | 2 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Merz North America, Inc. | 1 | $20 |
| Amgen | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Medtronic | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $15 |
| Si-bone, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,879 in reported general payments places this provider in the 65th percentile of 20 pain medicine providers in Alaska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $9,479 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $24 | $9,47912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 20 pain medicine providers in Alaska.
Other pain medicine in Wasilla
- Stephen MarkewichWasilla$57K
- Renee MarchegianiWasilla$10K
- Derek BradleyJber$9K
- Kimpreet KaurElmendorf Afb$7K
- James PricePalmer$7K
- Nichelle RenkAnchorage$5K
- Benjamin EkstromAnchorage$910
- Leon ChandlerAnchorage$836
- Nancy CrossFairbanks$707
- Shawn JohnstonAnchorage$663
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.